Results 41 to 50 of about 2,461 (207)

Cationic supramolecular hydrogels for overcoming the skin barrier in drug delivery [PDF]

open access: yes, 2018
A cationic bis‐imidazolium‐based amphiphile was used to form thermoreversible nanostructured supramolecular hydrogels incorporating neutral and cationic drugs for the topical treatment of rosacea.
Amabilino, David B.   +6 more
core   +1 more source

Therapeutic approaches with intravitreal injections in geographic atrophy secondary to age-related macular degeneration: current drugs and potential molecules [PDF]

open access: yes, 2019
The present review focuses on recent clinical trials that analyze the efficacy of intravitreal therapeutic agents for the treatment of dry age-related macular degeneration (AMD), such as neuroprotective drugs, and complement inhibitors, also called ...
Cerini, Alberto   +5 more
core   +1 more source

Efficacy of selective laser trabeculoplasty for normal tension glaucoma: 1 year results [PDF]

open access: yes, 2015
BACKGROUND: Normal tension glaucoma (NTG) is commonly treated with anti-glaucoma medications. Recently, selective laser trabeculoplasty (SLT) has been demonstrated to lower the intraocular pressure (IOP) and medication use in NTG.
Chan, JC, Ho, WL, Lai, JS, Lee, WYJ
core   +4 more sources

Safety, tolerability, and efficacy of fixed combination therapy with dorzolamide hydrochloride 2% and timolol maleate 0.5% in glaucoma and ocular hypertension. [PDF]

open access: yes, 2010
Glaucoma is a collection of diseases characterized by multifactorial progressive changes leading to visual field loss and optic neuropathy most frequently due to elevated intraocular pressure (IOP).
Bell, Nicholas P   +2 more
core   +3 more sources

Respiratuvar depression after accidental nasal ingestion of brimonidine eye drops in infant

open access: yesTurkish Journal of Emergency Medicine, 2016
Objectives: Brimonidine tartrate is an alpha-2 agonist used for glaucoma treatment. It can lead to serious poisoning symptoms when misused by children.
Ali Gunes   +4 more
doaj   +1 more source

Changes in visual function after intraocular pressure reduction using antiglaucoma medications [PDF]

open access: yes, 2009
Purpose To evaluate the change in visual function after starting glaucoma treatment and correlate this to a decrease in intraocular pressure (IOP) in primary open-angle glaucoma patients.Methods A prospective, randomized clinical trial was carried out ...
A Harris   +22 more
core   +2 more sources

Use of an alternative method to evaluate erythema severity in a clinical trial: difference in vehicle response with evaluation of baseline and postdose photographs for effect of oxymetazoline cream 1·0% for persistent erythema of rosacea in a phase IV study. [PDF]

open access: yes, 2019
BackgroundOnce-daily topical oxymetazoline cream 1·0% significantly reduced persistent facial erythema of rosacea in trials requiring live, static patient assessments.ObjectivesTo evaluate critically the methodology of clinical trials that require live ...
Alvandi, N   +10 more
core   +1 more source

Alteração do filme lacrimal e superfície ocular em usuários crônicos de medicação antiglaucomatosa [PDF]

open access: yes, 2008
PURPOSE: Tear film can be altered by chronic medications that may disrupt the equilibrium responsible for the functioning of the lacrimal gland and ocular surface.
BAFFA, Lina do Prado   +7 more
core   +2 more sources

Prophylactic effect of brimonidine to minimize the incidence of subconjunctival hemorrhage in the early postoperative period after 23G pars plana vitrectomy [PDF]

open access: yes, 2021
Background: Several studies have investigated and demonstrated the prophylactic effect of brimonidine drops in preventing subconjunctival hemorrhage in some microincisional ophthalmic surgeries, such as intravitreal injections or cataract surgery ...
Barón-García, Marisa   +7 more
core   +1 more source

Патогенетически ориентированное лечение первично-хронического глазного ишемического синдрома с использованием местных гипотензивных препаратов [PDF]

open access: yes, 2008
Призначення травопроста 0,004% пацієнтам з даною патологією призводить до більш суттєвого підвищення об’ємних показників кровотоку і як наслідок зорових функцій у порівнянні з брімоніна тартратом 0,2%, латанопростом 0,005% і бетаксололом 0,25 ...
Завгородняя, Н.Г.   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy